Cosmo Pharmaceuticals has revealed topline results from two phase 3 trials which indicate that its topical cream clascoterone ...
The overlap between the work of J&J and Watts has led to a joint push to get women over 40 to focus on eye health. Together, ...
The phase 3 comeback story that Bristol Myers Squibb investors were eagerly anticipating is not to be—at least not this year.
Artificial intelligence chemistry outfit Excelsior Sciences is gaining ground on its quest to hasten the discovery and production of small molecules. | Excelsior Sciences, which spun out of investment ...
As the U.S. focuses on beefing up its biopharma manufacturing infrastructure this year, a similar effort toward improved drug ...
Two-thirds of respondents who have faced fertility challenges said their workplaces don’t offer support for employees undergoing fertility treatment. Support is rarest in France, where 88% of ...
In a Q&A for Fierce Pharma Marketing’s “Rising Stars” series, Daniel McIver spoke about the challenges and rewards of his ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback